Excerpted from "About Us" on company Web site:
We research and develop biopharmaceutical products based on our patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. We believe the following areas of research offer the greatest potential for our product development efforts:
- Vaccines for use in high-risk populations for infectious disease targets for which there are significant U.S. needs,
- Vaccines for general pediatric, adolescent and adult populations for infectious disease applications, and
- Cancer vaccines or immunotherapies which complement our existing programs and core expertise.
